Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Regulus Therapeutics Inc. (RGLS) had Tangible Shareholders Equity of $69.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-9.63M |
|
-- |
|
-- |
|
$10.54M |
|
$-10.54M |
|
$0.90M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-10.54M |
|
$-10.65M |
|
66.17M |
|
66.17M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$71.69M |
|
$1.12M |
|
$3.13M |
|
$74.83M |
|
$4.40M |
|
-- |
|
$1.40M |
|
$5.80M |
|
$69.02M |
|
|
Tangible Shareholders Equity |
$69.00M |
$69.03M |
|
66.28M |
|
| Cash Flow Statement Financials | |
$-10.61M |
|
$21.50M |
|
$0.04M |
|
$38.59M |
|
$49.52M |
|
$10.93M |
|
$2.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.96% |
|
-13.96% |
|
-12.88% |
|
-13.96% |
|
$1.04 |
|
$-0.16 |
|
$-0.16 |
|